AI assistant
Liquidia Corp — Director's Dealing 2023
Apr 10, 2023
31694_dirs_2023-04-10_4cd66f9b-a9cb-4572-a7d4-c7e495a00cfa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2022-08-31
Reporting Person: JEFFS ROGER (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-31 | Common Stock | A | 993 | $4.9045 | Acquired | 116007 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 46595 | Indirect |
| Common Stock | 1541667 | Indirect |
Footnotes
F1: The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F2: The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.
F3: This amendment is being filed solely to add this footnote 3 and to correct the transaction code in box 3 above. These shares of common stock were acquired on August 31, 2022 through the Liquidia Corporation 2020 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).